论文信息 - Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial - 字舞流文

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial

M. Lebwohl | J. Silverberg | T. Bieber | E. Simpson | C. Feeney | P. Biswas | H. Valdez | M. Dibonaventura | R. Rojo | A. Blauvelt | C. Lynde | F. Valenzuela | P. Criado | S. Eisman | Jacek Zdybski | W. Gubelin | Tahira Khan | M. Cameron | J. Zdybski